HOUSTON, July 9, 2019 /PRNewswire/ -- Researchers at Baylor College of Medicine and Medterra CBD, one of the leaders in the CBD category, announced a collaborative study to explore the verifiable effects of cannabidiol (CBD), a THC-free product derived from the cannabis plant, with the hope of deriving a scientifically accurate viewpoint regarding CBD and its biological capabilities.
"This is an important study as we continue to see CBD surge in popularity, despite little scientific evidence to support patient claims of easing pain, reducing anxiety and helping with cognition and movement disorders," said Dr. Matthew Halpert, instructor of immunology at Baylor. "With this study, we want to perform the necessary tests to verify CBD's benefits, with the hope of determining, for instance, if the product reduces cartilage damage associated with arthritis."
Medterra CBD, a California-based company that makes CBD isolate derived from THC-free hemp, strives to follow the science as the industry works to transition towards mainstream acceptance. The company approached Baylor College of Medicine to conduct an independent academic study on several of Medterra CBD's products. Halpert and his team will attempt to quantify the effects of Medterra's CBD products, which include capsules, tinctures and lotions.
"We're thrilled to be partnering with Baylor College of Medicine and Dr. Halpert on this groundbreaking research," said Jay Hartenbach, CEO and co-founder of Medterra CBD. "As the industry continues to grow and more consumers become interested in the power of CBD, we have a responsibility to provide them with the best possible user experience, backed by true research. Through our work with Baylor we'll be able to do just that, while also improving and innovating future Medterra CBD products."
Though CBD has been available for sale in the U.S. for the last four years, Medterra CBD's focus on scientific validation is unique in the category, and a departure from sole reliance on testimonial and anecdotal reviews of products often seen with much of the CBD industry.
This study is funded and sponsored by Medterra. For interviews with Dr. Halpert, please contact Homa Shalchi at [email protected] or (713) 798-4710.
Medterra is also working with Baylor College of Medicine to study the scientific effects of its CBD Pet Product line, and looks forward to sharing more information about those findings later this year.
ABOUT MEDTERRA CBD, INC.
Medterra's CBD is extracted from industrial hemp grown in accordance with the strict guidelines of the Kentucky Department of Agriculture's Hemp Pilot Research Program. Each product is third-party tested to ensure consistency and quality. For Medterra, follow @medterracbd on Instagram and on Facebook: www.facebook.com/MedterraCBD
ABOUT BAYLOR COLLEGE OF MEDICINE
Baylor College of Medicine (www.bcm.edu) in Houston is recognized as health sciences university and is known for excellence in education, research and patient care. It is the only private medical school in the greater southwest and is ranked 22nd among medical schools for research and 4th for primary care by U.S. News & World Report. Baylor is listed 20th among all U.S. medical schools for National Institutes of Health funding and No. 1 in Texas. The Baylor pediatrics program ranked 8th among all pediatric programs, reflecting the strong affiliation with Texas Children's Hospital where our faculty care for pediatric patients and our students and residents train. Nationally our physician assistant program was ranked 3rd in the health disciplines category and our nurse anesthesia program ranked 2nd. Located in the Texas Medical Center, Baylor has affiliations with seven teaching hospitals and jointly owns and operates Baylor St. Luke's Medical Center, part of CHI St. Luke's Health. Currently, Baylor has more than 3,000 trainees in medical, graduate, nurse anesthesia, physician assistant, orthotics and genetic counseling as well as residents and postdoctoral fellows. Follow Baylor College of Medicine on Facebook (http://www.facebook.com/BaylorCollegeOfMedicine) and Twitter (http://twitter.com/BCMHouston).
SOURCE Medterra CBD